Actualizado: Problemas de mamografía en Advanced Women Imaging en Guttenberg, NJ

English Actualización – 7 de febrero de 2023: El certificado de la Ley de estándares de calidad de mamografía (MQSA, por sus siglas en inglés) para Advanced Women Imaging (en inglés), en 6414 Bergenline Avenue, West New York, NJ (Bergenline) fue revocado hasta el 4 de enero de 2025. Actualmente, el centro no está acreditado…

Volt Candy Issues Voluntary Nationwide Recall of PrimeZen Black 6000 Capsules Due to Presence of Sildenafil and Tadalafil

Summary Company Announcement Date: February 13, 2023 FDA Publish Date: February 13, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Product contains undeclared tadalafil and sildenafil Company Name: Volt Candy Brand Name: Brand Name(s) Product Description: Product Description PrimeZEN Black 6000 male enhancement capsules Company Announcement FOR IMMEDIATE RELEASE – 2/13/2023 – Pomona,…

Universal Meditech Inc. Issues Nationwide Recall of Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test Kit

Summary Company Announcement Date: February 09, 2023 FDA Publish Date: February 10, 2023 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Products were distributed without appropriate premarket clearance or approval which potentially could result in inaccurate test results due to lack of performance evaluation by the FDA. Company Name: Universal Meditech Inc. Brand…

2023 Safety Communications

The FDA posts Medical Device Safety Communications to describe the FDA’s current analysis of an issue and contain specific regulatory approaches and clinical recommendations for patient management. 2023 Safety Communications Content current as of: 02/07/2023 Article source: http://www.fda.gov/medical-devices/safety-communications/2023-safety-communications

Updated: Mammography Problems at Advanced Women Imaging in Guttenberg, NJ

Update – February 7, 2023: The Mammography Quality Standards Act (MQSA) certificate for Advanced Women Imaging, located at 6414 Bergenline Avenue, West New York, NJ (Bergenline) was revoked until January 4, 2025. The facility is currently unaccredited, uncertified, and cannot legally perform mammography. Additionally, the FDA has identified two individuals that qualify as owners or…

Smiths Medical Recalls Certain CADD System Administration Sets and Cassette Reservoirs for Issues Causing Delay, Interruption, or Under-Delivery of Therapy

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product  Product Name: CADD infusion system Administration Sets and Cassette Reservoirs  Product Models: See Medical Device Recall Database entries Distribution Dates: June 15, 2018 to present Devices Recalled…

Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination

Summary Company Announcement Date: February 02, 2023 FDA Publish Date: February 02, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential microbial contamination Company Name: Global Pharma Healthcare Brand Name: Brand Name(s) EzriCare & Delsam Pharma Product Description: Product Description Artificial Tears Lubricant Eye Drops Company Announcement Global Pharma Healthcare is voluntarily recalling…

IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution Due to Subpotency

Summary Company Announcement Date: January 31, 2023 FDA Publish Date: February 01, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Subpotency Company Name: IBSA Pharma Inc. Brand Name: Brand Name(s) Product Description: Product Description TIROSINT®-SOL (levothyroxine sodium) Company Announcement IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution…